333 related articles for article (PubMed ID: 11940053)
41. Cushing's syndrome due to an ectopic ACTH-secreting pituitary tumour mimicking occult paraneoplastic ectopic ACTH production.
Bethge H; Arlt W; Zimmermann U; Klingelhöffer G; Wittenberg G; Saeger W; Allolio B
Clin Endocrinol (Oxf); 1999 Dec; 51(6):809-14. PubMed ID: 10619988
[TBL] [Abstract][Full Text] [Related]
42. Localization of pituitary adenomas by using intraoperative ultrasound in patients with Cushing's disease and no demonstrable pituitary tumor on magnetic resonance imaging.
Watson JC; Shawker TH; Nieman LK; DeVroom HL; Doppman JL; Oldfield EH
J Neurosurg; 1998 Dec; 89(6):927-32. PubMed ID: 9833817
[TBL] [Abstract][Full Text] [Related]
43. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
44. Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing's syndrome.
Lienhardt A; Grossman AB; Dacie JE; Evanson J; Huebner A; Afshar F; Plowman PN; Besser GM; Savage MO
J Clin Endocrinol Metab; 2001 Dec; 86(12):5711-4. PubMed ID: 11739426
[TBL] [Abstract][Full Text] [Related]
45. Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
Tampanaru-Sarmesiu A; Stefaneanu L; Thapar K; Kovacs K; Donnelly T; Metz CN; Bucala R
Arch Pathol Lab Med; 1997 Apr; 121(4):404-10. PubMed ID: 9140312
[TBL] [Abstract][Full Text] [Related]
46. Double pituitary adenomas: a series of three patients.
McKelvie PA; McNeill P
Pathology; 2002 Feb; 34(1):57-60. PubMed ID: 11902447
[TBL] [Abstract][Full Text] [Related]
47. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.
López J; Barceló B; Lucas T; Salame F; Alameda C; Boronat M; Salto L; Estrada J
Clin Endocrinol (Oxf); 1996 Aug; 45(2):147-56. PubMed ID: 8881446
[TBL] [Abstract][Full Text] [Related]
48. A study of corticotroph adenomas in Cushing's disease: no evidence of intermediate lobe origin.
McNicol AM; Teasdale GM; Beastall GH
Clin Endocrinol (Oxf); 1986 Jun; 24(6):715-22. PubMed ID: 3024871
[TBL] [Abstract][Full Text] [Related]
49. ACTH, beta-LPH and beta-endorphin in pituitary adenomas of the patients with Cushing's disease: activation of beta-LPH conversion to beta-endorphin.
Suda T; Abe Y; Demura H; Demura R; Shizume K; Tamahashi N; Sasano N
J Clin Endocrinol Metab; 1979 Sep; 49(3):475-7. PubMed ID: 224076
[TBL] [Abstract][Full Text] [Related]
50. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level.
Pagotto U; Marsicano G; Fezza F; Theodoropoulou M; Grübler Y; Stalla J; Arzberger T; Milone A; Losa M; Di Marzo V; Lutz B; Stalla GK
J Clin Endocrinol Metab; 2001 Jun; 86(6):2687-96. PubMed ID: 11397872
[TBL] [Abstract][Full Text] [Related]
51. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
Reimondo G; Paccotti P; Minetto M; Termine A; Stura G; Bergui M; Angeli A; Terzolo M
Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
[TBL] [Abstract][Full Text] [Related]
52. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
Shimon I; Hinton DR; Weiss MH; Melmed S
Clin Endocrinol (Oxf); 1998 Jan; 48(1):23-9. PubMed ID: 9509064
[TBL] [Abstract][Full Text] [Related]
53. Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours.
Vieau D; Linard CG; Mbikay M; Lenne F; Chretien M; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1992 Jun; 36(6):597-603. PubMed ID: 1424185
[TBL] [Abstract][Full Text] [Related]
54. Peptides related to alpha-melanocyte-stimulating hormone are commonly produced by human pituitary corticotroph adenomas: no relationship with pars intermedia origin.
Coates PJ; Doniach I; Wells C; Hale AC; Rees LH; Besser GM
J Endocrinol; 1989 Mar; 120(3):531-6. PubMed ID: 2538539
[TBL] [Abstract][Full Text] [Related]
55. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
[TBL] [Abstract][Full Text] [Related]
56. Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro.
Pecori Giraldi F; Bucciarelli LG; Saccani A; Scacchi M; Pesce S; Losa M; Cavagnini F
J Neuroendocrinol; 2007 Mar; 19(3):208-12. PubMed ID: 17280594
[TBL] [Abstract][Full Text] [Related]
57. [Pathology and pathogenesis of pituitary corticotroph adenoma].
Trouillas J
Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
[TBL] [Abstract][Full Text] [Related]
58. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
Kim D; Ku CR; Park SH; Moon JH; Kim EH; Kim SH; Lee EJ
World Neurosurg; 2018 Jul; 115():e464-e471. PubMed ID: 29678704
[TBL] [Abstract][Full Text] [Related]
59. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study.
Desai B; Burrin JM; Nott CA; Geddes JF; Lamb EJ; Aylwin SJ; Wood DF; Thakkar C; Monson JP
Eur J Endocrinol; 1995 Jul; 133(1):25-32. PubMed ID: 7542980
[TBL] [Abstract][Full Text] [Related]
60. Endothelin expression in normal human anterior pituitaries and pituitary adenomas.
Lange M; Pagotto U; Hopfner U; Ehrenreich H; Oeckler R; Sinowatz F; Stalla GK
J Clin Endocrinol Metab; 1994 Dec; 79(6):1864-70. PubMed ID: 7527415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
